MENU

AVDL Stock Avadel Pharmaceuticals (AVDL, $18.7) was a top quarterly gainer, rising +39.55%

A.I.dvisor
at Tickeron.com
Loading...
AVDL - Avadel Pharmaceuticals plc
Tickeron

Loading...

Price: $18.7
Daily change: +$0.01 (+0.05%)
Daily volume: 2M
3-month price change: +$5.3 (+39.55%)
Capitalization: $1.8B
Industry: Pharmaceuticals: Generic

Avadel Pharmaceuticals (AVDL, $18.7) was one of top quarterly gainers, jumping +3 to $18.7 per share. A.I.dvisor analyzed 216 stocks in the Pharmaceuticals: Generic Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down.

AVDL in upward trend: 10-day moving average crossed above 50-day moving average on October 21, 2025

The 10-day moving average for AVDL crossed bullishly above the 50-day moving average on October 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2025. You may want to consider a long position or call options on AVDL as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AVDL moved above its 50-day moving average on October 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVDL advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 171 cases where AVDL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where AVDL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVDL turned negative on November 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVDL broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVDL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.120) is normal, around the industry mean (18.827). P/E Ratio (0.000) is within average values for comparable stocks, (71.764). AVDL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). AVDL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (7.657) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
AVDL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVDL showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
10 Earlsfort Terrace
Phone
+353 19015201
Employees
154
Web
https://www.avadel.com